Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CYPROTERONE ACETATE, ETHINYLESTRADIOL
Clear Pharma Limited
G03HB01
CYPROTERONE ACETATE, ETHINYLESTRADIOL
2/35 mg/mcg
Coated Tablets
Product subject to prescription which may be renewed (B)
Antiandrogens and estrogens
Authorised
2014-04-11
PACKAGE LEAFLET: INFORMATION FOR THE USER DIANETTE® 2MG/35 MICROGRAMS COATED TABLETS cyproterone acetate/ethinylestradiol _ _ _ This medicine is subject to additional monitoring. This will allow _ _quick identification of new safety information. You can help by _ _reporting any side effects you may get. See the end of section 4 for how _ _to report side effects. _ IN THIS LEAFLET 1. What Dianette is and what it is used for 2. What you need to know before you take Dianette Do not take Dianette Warnings and precautions Dianette and venous and arterial blood clots Dianette and cancer Bleeding between periods What to do if no bleeding occurs during the gap week Other medicines and Dianette Taking Dianette with food and drink Laboratory tests Pregnancy Breast-feeding Driving and using machines Dianette contains lactose and sucrose 3. How to take Dianette When to start with the first strip If you take more Dianette than you should If you forget to take Dianette What to do in the case of vomiting or severe diarrhoea If you stop taking Dianette 4. Possible side effects 5. How to store Dianette 6. Contents of the pack and other information 1. WHAT DIANETTE IS AND WHAT IT IS USED FOR Dianette is used to treat skin conditions such as acne, very oily skin and excessive hair growth in women of reproductive age. Due to its contraceptive properties it should only be prescribed for you if your doctor considers that treatment with a hormonal contraceptive is appropriate. You should only take Dianette if your skin condition has not improved after use of other anti-acne treatments, including topical treatments and an Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1 NAME OF THE MEDICINAL PRODUCT Dianette 2mg/35 microgram coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2mg cyproterone acetate and 0.035mg ethinylestradiol. Excipients: contains lactose and sucrose For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Coated tablet (tablet). _Product imported from the UK:_ Beige, sugar-coated, biconvex tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. For the treatment of acne, Dianette should only be used after topical therapy or systemic antibiotic treatments have failed. Since Dianette is also a hormonal contraceptive, it should not be used in combination with other hormonal contraceptives (see section 4.3). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Method of Administration: Oral use DOSAGE REGIMEN HOW TO TAKE DIANETTE Dianette is to be taken regularly in order to achieve the therapeutic efficacy and the required contraceptive protection. Combined oral contraceptives when taken correctly have a failure rate of approximately 1 % per year. Tablets must be taken in the order directed on the package every day at about the same time with some liquid as needed. One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-free interval, during which time a withdrawal bleed usually occurs. This usually starts on day 2 Read the complete document